<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(8)</volume><submitter>Zhang Q</submitter><pubmed_abstract>&lt;i>Akkermansia muciniphila&lt;/i> (&lt;i>Akk&lt;/i>) has recently become popular due to its therapeutic effect on various diseases. However, &lt;i>Akk&lt;/i>'s high-density cultivation is difficult due to its anaerobic characteristics. Therefore, &lt;i>Akk&lt;/i> was cultured with modified brain-heart infusion (M-BHI) to reach 10&lt;sup>11&lt;/sup> CFU/mL. &lt;sup>1&lt;/sup>H-NMR determined the metabolites of &lt;i>Akk&lt;/i> and validated them by an amino acid analyzer. Compared to the BHI, &lt;i>Akk&lt;/i> significantly up-regulated lactate, histidine, fumaric acid, cytidine, threonine, arginine, and hydroxyproline in the M-BHI and significantly down-regulated methionine, trimethylamine, and sarcosine. Regarding pathway enrichment analysis, histidine metabolism, arginine and proline metabolism, cysteine and methionine metabolism mainly regulate differential metabolites. In addition, M-BHI alters the metabolic profile by affecting &lt;i>Akk&lt;/i>'s involvement in amino acid metabolism remodeling. Changed metabolites showed that &lt;i>Akk&lt;/i> fermentation in M-BHI may play a physiological role in regulating immune homeostasis and reducing risk factors related to diseases. Therefore, M-BHI provides a promising reference for &lt;i>Akk&lt;/i> cultivation in future industrial preparation.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1007/s10068-023-01492-x.</pubmed_abstract><journal>Food science and biotechnology</journal><pagination>1921-1930</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11091034</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of modified-BHI medium on the growth and metabolites of &amp;lt;i&amp;gt;Akkermansia muciniphila&amp;lt;/i&amp;gt;.</pubmed_title><pmcid>PMC11091034</pmcid><pubmed_authors>Chi P</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Zhou F</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>He Q</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Zhao H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of modified-BHI medium on the growth and metabolites of &amp;lt;i&amp;gt;Akkermansia muciniphila&amp;lt;/i&amp;gt;.</name><description>&lt;i>Akkermansia muciniphila&lt;/i> (&lt;i>Akk&lt;/i>) has recently become popular due to its therapeutic effect on various diseases. However, &lt;i>Akk&lt;/i>'s high-density cultivation is difficult due to its anaerobic characteristics. Therefore, &lt;i>Akk&lt;/i> was cultured with modified brain-heart infusion (M-BHI) to reach 10&lt;sup>11&lt;/sup> CFU/mL. &lt;sup>1&lt;/sup>H-NMR determined the metabolites of &lt;i>Akk&lt;/i> and validated them by an amino acid analyzer. Compared to the BHI, &lt;i>Akk&lt;/i> significantly up-regulated lactate, histidine, fumaric acid, cytidine, threonine, arginine, and hydroxyproline in the M-BHI and significantly down-regulated methionine, trimethylamine, and sarcosine. Regarding pathway enrichment analysis, histidine metabolism, arginine and proline metabolism, cysteine and methionine metabolism mainly regulate differential metabolites. In addition, M-BHI alters the metabolic profile by affecting &lt;i>Akk&lt;/i>'s involvement in amino acid metabolism remodeling. Changed metabolites showed that &lt;i>Akk&lt;/i> fermentation in M-BHI may play a physiological role in regulating immune homeostasis and reducing risk factors related to diseases. Therefore, M-BHI provides a promising reference for &lt;i>Akk&lt;/i> cultivation in future industrial preparation.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1007/s10068-023-01492-x.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-04T01:24:32.661Z</modification><creation>2025-04-04T01:24:32.661Z</creation></dates><accession>S-EPMC11091034</accession><cross_references><pubmed>38752110</pubmed><doi>10.1007/s10068-023-01492-x</doi></cross_references></HashMap>